Literature DB >> 16377723

OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia.

Anton Y Peleg, Clare Franklin, Luke J Walters, Jan M Bell, Denis W Spelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16377723      PMCID： PMC1346810          DOI： 10.1128/AAC.50.1.399-400.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

Review 1.  Emerging carbapenemases in Gram-negative aerobes.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2002-06       Impact factor: 8.067

2.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Thierry Lambert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme.

Authors:  J J Yan; P R Hsueh; W C Ko; K T Luh; S H Tsai; H M Wu; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

6.  A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.

Authors:  Claire Héritier; Anne Dubouix; Laurent Poirel; Nicole Marty; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2004-12-08       Impact factor: 5.790

7.  Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia.

Authors:  Anton Y Peleg; Clare Franklin; Jan M Bell; Denis W Spelman
Journal:  Clin Infect Dis       Date:  2005-10-31       Impact factor: 9.079

8.  Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina.

Authors:  S Brown; H K Young; S G B Amyes
Journal:  Clin Microbiol Infect       Date:  2005-01       Impact factor: 8.067

Review 9.  Acinetobacter outbreaks, 1977-2000.

Authors:  Maria Virginia Villegas; Alan I Hartstein
Journal:  Infect Control Hosp Epidemiol       Date:  2003-04       Impact factor: 3.254

10.  Septicemia due to Acinetobacter junii.

Authors:  Hans-Jörg Linde; Joachim Hahn; Ernst Holler; Udo Reischl; Norbert Lehn
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948
View more
  16 in total

Review 1.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

2.  Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.

Authors:  Sara Marti; Javier Sánchez-Céspedes; M Dolores Blasco; Marc Ruiz; Paula Espinal; Verónica Alba; Felipe Fernández-Cuenca; Alvaro Pascual; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

3.  First report of blaNDM and blaOXA-58 coexistence in Acinetobacter junii.

Authors:  Handal Regeen; Dalia Al-Sharafa-Kittaneh; Randa Kattan; Rula Al-Dawodi; Hiyam Marzouqa; Musa Y Hindiyeh
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

4.  A case of IMP-4-, OXA-421-, OXA-96-, and CARB-2-producing Acinetobacter pittii sequence type 119 in Australia.

Authors:  Witchuda Kamolvit; Petra Derrington; David L Paterson; Hanna E Sidjabat
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

5.  Contribution of a plasmid-borne blaOXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in acinetobacter genomic species 13TU.

Authors:  Te-Li Chen; Wei-Che Chang; Shu-Chen Kuo; Yi-Tzu Lee; Chien-Pei Chen; Leung-Kei Siu; Wen-Long Cho; Chang-Phone Fung
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

Review 6.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

7.  Genome and Plasmid Analysis of blaIMP-4-Carrying Citrobacter freundii B38.

Authors:  Jianhui Xiong; Maxime Déraspe; Naeem Iqbal; Jennifer Ma; Frances B Jamieson; Jessica Wasserscheid; Ken Dewar; Peter M Hawkey; Paul H Roy
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 9.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 10.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.